CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (unaudited) - USD ($) $ in Thousands		Dec. 31, 2022	Dec. 31, 2021
Investments
Total investments		$ 301,084	$ 412,144	[1]
Cash and cash equivalents		587	9,132
Restricted cash			13
Receivable for investments sold		396	766
Interest receivable		3,090	1,811
Dividends receivable		1,440	1,540
Due from portfolio company		1	136
Due from affiliates			17
Deferred financing costs		226	376
Prepaid expenses and other assets		3,288	379
Total assets		310,112	426,314
Liabilities
Notes payable (including unamortized discount of $2,781 and $3,935, respectively)		143,152	141,998
Revolving credit facility		10,000
Payable for investments purchased		70,022	203,575
Interest payable		42	29
Accrued incentive fees payable		565	4,854
Due to affiliates		1,042	1,012
Accrued expenses and other liabilities		480	290
Total liabilities		225,303	351,758
Commitments and contingencies (Note 7)
Net Assets
Common stock, par value $0.01 per share (100,000,000 shares authorized, 7,601,958 shares issued and outstanding and 4,484,278 shares issued and outstanding, respectively)	[2]	76	45
Additional paid-in capital		284,107	245,531
Accumulated losses		(199,374)	(171,020)
Total net assets		84,809	74,556
Total liabilities and net assets		$ 310,112	$ 426,314
Net asset value per share	[2],[3]	$ 11.16	$ 16.63
Non-affiliated, Non-controlled Investments
Investments
Total investments		$ 171,743	$ 164,203
Non-affiliated, Non-controlled Short-term Investments
Investments
Total investments		76,127	199,995
Affiliated Investments
Investments
Total investments		1,304	10,861
Controlled Investments
Investments
Total investments		$ 51,910	$ 37,085

[1] As of period end, the aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost was $49,821; the aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value was $162,667; the net unrealized depreciation was $(112,846); the aggregate cost of securities for Federal income tax purposes was $524,990.

[2] Authorized, issued and outstanding shares of common stock and net asset value per share have been adjusted for the periods shown to reflect the six-for-one reverse stock split effected on February 28, 2022 on a retroactive basis as described in Note 2.

[3] The per share data was derived by using the weighted average shares outstanding during the period, except where such calculations deviate from those specified under the instructions to Form N-2. Per share data and shares outstanding have been adjusted for the periods shown to reflect the six-for-one reverse stock split effected on February 28, 2022 on a retrospective basis, as described in Note 2.